Cargando…
Refining prediction of major bleeding on antiplatelet treatment after transient ischaemic attack or ischaemic stroke
INTRODUCTION: Bleeding is the main safety concern of treatment with antiplatelet drugs. We aimed to refine prediction of major bleeding on antiplatelet treatment after a transient ischaemic attack (TIA) or stroke by assessing the added value of new predictors to the existing S(2)TOP-BLEED score. PAT...
Autores principales: | Hilkens, Nina A, Li, Linxin, Rothwell, Peter M, Algra, Ale, Greving, Jacoba P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7309362/ https://www.ncbi.nlm.nih.gov/pubmed/32637646 http://dx.doi.org/10.1177/2396987319898064 |
Ejemplares similares
-
External Validation of Risk Scores for Major Bleeding in a Population-Based Cohort of Transient Ischemic Attack and Ischemic Stroke Patients
por: Hilkens, Nina A., et al.
Publicado: (2018) -
Early time course of major bleeding on antiplatelet therapy after TIA or ischemic stroke
por: Hilkens, Nina A., et al.
Publicado: (2018) -
Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials
por: Rothwell, Peter M, et al.
Publicado: (2016) -
Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack
por: Wang, Yongjun, et al.
Publicado: (2019) -
Balancing Benefits and Risks of Long-Term Antiplatelet Therapy in Noncardioembolic Transient Ischemic Attack or Stroke
por: Hilkens, Nina A., et al.
Publicado: (2021)